Bg pattern
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use ERBIUM CITRATE (169Er) colloidal CIS BIO INTERNACIONAL 111 MBq/ML INJECTABLE SUSPENSION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show translation

Introducción

Prospecto: información para el paciente

Citrato de erbio (169Er) coloidal CIS bio international 111 MBq/ml suspensión inyectable

citrato de erbio (169Er)

Lea todo el prospecto detenidamente antes de empezar a usar este medicamento porque contiene información importante para usted..

  • Conserve este prospecto, ya que puede tener que volver a leerlo.
  • Si tiene alguna duda, consulte al médico nuclear que supervisa el procedimiento.
  • Si experimenta efectos adversos, consulte al médico nuclear, incluso si se trata de efectos adversos que no aparecen en este prospecto.Ver sección 4.

Contenido del prospecto:

1.Qué es Citrato de erbio (169Er) coloidal CIS bio international y para qué se utiliza

2.Antes de usar Citrato de erbio (169Er) coloidal CIS bio international

3.Cómo usar Citrato de erbio (169Er) coloidal CIS bio international

4.Posibles efectos adversos

5.Conservación de Citrato de erbio (169Er) coloidal CIS bio international

6.Contenido del envase e información adicional

1. Qué es Citrato de erbio (169Er) coloidal CIS bio international y para qué se utiliza

Este medicamento es un radiofármaco únicamente para uso terapéutico.

Citrato de erbio (169Er) coloidal CIS bio international está indicado en adultos en el tratamiento de las artritis durante los brotes inflamatorios de las articulaciones pequeñas de la mano y el pie, cuando fracasa el tratamiento intraarticular con corticoides, o cuando éste está contraindicado.

La administración de Citrato de erbio (169Er) coloidal CIS bio international implica recibir una pequeña cantidad de radiactividad. Su médico y el médico nuclear consideran que el beneficio clínico que usted obtendrá de este procedimiento con el radiofármaco es supera el riesgo debido a la radiación.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. Qué necesita saber antes de empezar a usar Citrato de erbio (169Er) coloidal CIS bio international

Citrato de erbio (169Er) coloidal CIS bio international no debe utilizarse:

  • Si es alérgico (hipersensible) al citrato de erbio (169Er) o a alguno de los demás componentes de este medicamento (indicados en la sección 6).
  • Si usted está embarazada o cree que puede estarlo.
  • Usted está dando el pecho a su hijo/a.
  • En niños y pacientes jóvenes menores de 20 años.
  • Si usted sufre una infección en la articulación a tratar.
  • Si usted sufre infecciones locales o presencia de alteraciones de piel en la zona de inyección.
  • Si tiene una rotura reciente de un quiste sinovial.

Advertencias y precauciones

Tenga especial cuidado con Citrato de erbio (169Er) coloidal CIS bio international y consulte al especialista en medicina nuclear:

  • Si usted se ha sometido a algún procedimiento con medios de contraste de rayos X en los últimos 3 días
  • Si usted es una mujer en edad fértil

Antes de la administración deCitrato de erbio (169Er) coloidal CIS bio internationaldebe evitar el embarazo mediante un método anticonceptivo efectivo mantenido durante varios meses después del tratamiento.

Niños y adolescentes

Comunique a su especialista en medicina nuclear si tiene menos de 20 años.

Uso de Citrato de erbio (169Er) coloidal CIS bio international con otros medicamentos:

Informe al especialista en medicina nuclear si está tomando, ha tomado recientemente o podría tener que tomar cualquier otro medicamento, incluso los adquiridos sin receta.

Informe a su médico nuclear si usted se ha sometido a algún procedimiento con medios de contraste de rayos X en los últimos 3 días porque puede interferir con el resultado del tratamiento.

Embarazo y lactancia

Si usted está embarazada o en periodo de lactancia, cree que podría estar embarazada o tiene intención de quedarse embarazada, consulte a su médico especialista en medicina nuclear antes de que se le administre este medicamento.

Debe informar a médico nuclear antes de la administración de Citrato de erbio (169Er) coloidal CIS bio international si existe alguna posibilidad de que esté embarazada, si presenta un retraso en el período o si está en periodo de lactancia. De hecho, el citrato de erbio (169Er) no debe ser administrado a mujeres embarazadas o en periodo de lactancia. Si usted es una mujer en edad fértil debe utilizar medidas anticonceptivas eficaces antes de la administración de este medicamento y mantenerlas varios meses después del tratamiento.

En caso de duda, es importante que consulte al médico especialista en medicina nuclear que supervisará el procedimiento.

Conducción y uso de máquinas

No se recomienda conducir vehículos o usar máquinas debido a la inmovilización de la articulación después de la administración.

Citrato de erbio (169Er) coloidal CIS bio international contiene menos de 23 mg de sodio (1mmol) por dosis; esto es, esencialmente “exento de sodio”.

3. Cómo se utiliza Citrato de erbio (169Er) coloidal CIS bio international

Hay normas estrictas sobre el uso, manipulación y eliminación de radiofármacos. Citrato de erbio (169Er) coloidal CIS bio international sólo se utilizará en instalaciones especiales controladas. Este producto sólo será manejado y le será administrado por personal entrenado y cualificado para usarlo de forma segura. Esas personas pondrán especial cuidado en el uso seguro de este producto y le informarán de sus acciones

El médico nuclear que supervise el procedimiento decidirá la cantidad de Citrato de erbio (169Er) coloidal CIS bio international que debe usarse en su caso. Esta será la cantidad mínima necesaria para obtener el efecto deseado. La cantidad generalmente recomendada para administrar a un adulto esde 10 a 80 MBq (Megabequerelio, la unidad utilizada para expresar la radiactividad) según la articulación a tratar.

Administración deCitrato deerbio (169Er) coloidalCIS bio international y realización del procedimiento

Citrato de erbio (169Er) coloidal CIS bio international lo inyecta su médico nuclear directamente en las articulaciones pequeñas de las manos y los pies.

Pueden ser tratadas varias articulaciones de forma simultánea o sucesiva

No se repite una inyección del producto radiactivo en una articulación hasta que han pasado al menos seis meses.

Después de la administración de Citrato de erbio (169Er) coloidal CIS bio international debería:

  • Tener la articulación inmovilizada 2 días (férulas o reposo en cama)
  • Usar un método anticonceptivo eficaz durante varios meses después del tratamiento para evitar cualquier embarazo.

El médico nuclear le informará si necesita tomar alguna precaución después de recibir este medicamento. Consulte a su médico nuclear si tiene alguna duda.

Si ha recibido másCitrato deerbio (169Er)coloidal CIS bio internationalde la que se debiera:

Es improbable una sobredosis porque usted recibirá una dosis única de Citrato de erbio (169Er) coloidal CIS bio international por articulación controlada con precisión por el médico nuclear que supervise el procedimiento. Sin embargo, en caso de sobredosis, usted recibirá el tratamiento apropiado.

Si tiene alguna duda sobre el uso de Citrato de erbio (169Er) coloidal CIS bio international, pregunte al médico nuclear que supervisa el procedimiento.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Posibles efectos adversos

Al igual que todos los medicamentos, este medicamento puede producir efectos adversos, aunque no todas las personas los sufran.

Los efectos adversos más frecuentemente observados tras la sinoviortesis con Citrato de erbio (169Er) coloidal CIS bio international son:

  • Muy frecuentes (pueden afectar amás de 1 cada 10 personas): dolor, inflamación del sitio de inyección, artritis aguda (reaparición de inflamación durante la primera semana después de la administración).
  • Frecuentes (pueden afectar hasta 1 de cada 10 personas): fiebre, disfunción de la movilidad de la articulación, pigmentación de la piel.
  • Muy raras (pueden afectar hasta 1 de cada 10.000 personas):enrojecimiento, alteración grave de la piel con ampollas.
  • Frecuencia no conocida (no puede estimarse a partir de los datos disponibles):infección secundaria en la articulación, inflamación de la articulación, necrosis de piel, sarpullido y picor.

Este radiofármaco liberará pequeñas cantidades de radiación ionizante asociada mínimamente al riesgo de cáncer o defectos hereditarios.

Comunicación de efectos adversos

Si experimenta cualquier tipo de efecto adverso, informe a su médico especialista en medicina nuclear, incluso si se trata de cualquier efecto adverso no incluido en este prospecto. También puede comunicarlos directamente a través del Sistema Español de Farmacovigilancia de Medicamentos de Uso Humano: https://www.notificaram.es.

Mediante la comunicación de efectos adversos usted puede contribuir a proporcionar más información sobre la seguridad de este medicamento.

5. Conservación de Citrato de erbio (169Er) coloidal CIS bio international

No tendrá que almacenar este medicamento. Este medicamento se almacena bajo la responsabilidad del especialista en instalaciones apropiadas. El almacenamiento de radiofármacos se realizará conforme a la normativa nacional sobre materiales radiactivos.

6. Contenido del envase e información adicional

Composición deCitrato deerbio (169Er) coloidalCIS bio international

  • El principio activo es Citrato de erbio (169Er).
  • Los demás componentes son: ácido nítrico, hidróxido de sodio, cloruro de sodio y agua para preparaciones inyectables.

Aspecto del Citrato de erbio (169Er) coloidal CIS bio international y contenido del envase

Citrato de erbio (169Er) coloidal CIS bio international se presenta en forma de suspensión inyectable, en vial multidosis.

Tamaño del envase: Viales de vidrio de 15 ml, sellados con tapón de goma y cápsula de aluminio. Contiene entre 0,1 y 10,0 ml, que corresponden a una actividad entre 11 y 1110 MBq a la fecha y hora de calibración.

Titular de la autorización de comercialización y responsable de la fabricación:

CIS bio international

RN 306 - Saclay

B.P. 32

F-91192 Gif-sur-Yvette Cedex

FRANCIA

Puede solicitar más información sobre este medicamento dirigiéndose al representante local del Titular de la autorización de comercialización:

Curium Pharma Spain, S.A. Avda. Dr. Severo Ochoa, 29

28100-Alcobendas

Tfno.: 91 4841989

Este prospecto fue revisado por última vez en Junio de 2020

La información detallada de este medicamento está disponible en la página Web de la Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) http://www.aemps.gob.es/

La siguiente información está destinada únicamente a médicos o profesionales sanitarios:

La ficha técnica completa de Citrato de erbio (169Er) coloidal CIS bio international se incluye como documento separado, en el envase del producto con el fin de proporcional a los profesionales sanitarios

otra información científica y práctica adicional sobre la administración y uso de este radiofármaco.

Por favor, consulte la Ficha Técnica.

Online doctors for ERBIUM CITRATE (169Er) colloidal CIS BIO INTERNACIONAL 111 MBq/ML INJECTABLE SUSPENSION

Discuss questions about ERBIUM CITRATE (169Er) colloidal CIS BIO INTERNACIONAL 111 MBq/ML INJECTABLE SUSPENSION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (100)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

5.0 (197)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

5.0 (1225)
Doctor

Andrei Popov

General medicine 7 years exp.

Dr. Andrei Popov is a family physician with specialized training in the management of chronic pain. He provides video consultations for adults in Spain and across Europe: whether you have been living with pain for months that no one has been able to properly explain, or you need to resolve a health issue without waiting weeks for an appointment.

His approach is clear: to listen, organize your case, and provide you with a practical roadmap based on evidence-based medicine and adapted to your medical history and personal needs.

Pain: how he can help

  • Chronic pain (more than 3 months
  • Migraine and recurrent or high-intensity headaches
  •  Neck, lower back, back and joint pain
  •  Post-traumatic pain after injuries or surgeries
  •  Pain of neurological origin: neuralgia, neuropathic pain, fibromyalgia

General medicine

  • Frequent respiratory infections (cold, flu, persistent cough)
  • Hypertension, diabetes and metabolic disorders
  • Review of laboratory tests and MRI/CT reports (explained in clear language)
  • Preventive medicine and health monitoring
  • Second opinions and treatment adjustments (when clinically appropriate)

What the consultation is like
 Each session lasts up to 30 minutes. We review symptoms, medical history, medications and any tests you provide, and you finish the consultation with a clear treatment plan, defined next steps, and criteria to understand when follow-up may be needed. If warning signs are detected, he will clearly advise whether you need in-person care or urgent medical attention.

4.6 (76)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate

Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

0.0 (10)
Doctor

Lizaveta Trafimchuk Takhvaniuk

Dermatology 10 years exp.

Dr. Lizaveta Trafimchuk Takhvaniuk graduated in Medicine and subsequently specialized in Dermatology and Venereology. She has more than 10 years of clinical experience and is licensed to practice in Spain, where she focuses on the comprehensive diagnosis and treatment of dermatological conditions.

Throughout her education and professional career, Dr. Trafimchuk has gained extensive experience in managing diseases of the skin, hair, and nails, as well as in the diagnosis, treatment, and prevention of sexually transmitted infections (STIs). Her clinical approach is based on evidence-based medicine, combined with personalized care tailored to each patient’s needs.

In her daily practice, she treats a wide range of dermatological conditions, including chronic inflammatory dermatoses such as acne, rosacea, atopic dermatitis, psoriasis, and eczema. She also has experience in treating pigmentation disorders, including melasma, post-inflammatory hyperpigmentation, and dyschromia.

She has developed a particular interest in trichology, treating various types of alopecia, chronic hair loss, and scalp disorders. In addition, she has experience in managing infectious dermatoses of fungal, viral, and bacterial origin, as well as in evaluating benign and suspicious skin lesions, with referral to specialized care when necessary.

With a strong interest in a comprehensive approach to skin health, she also treats scars, post-procedural skin changes, and conditions related to hormonal factors and aging, including those associated with pregnancy, menopause, and age-related skin changes.

Thanks to her experience and continuous professional development, Dr. Trafimchuk provides high-quality medical care that is professional, confidential, and aligned with modern dermatology standards.

0.0 (0)
Doctor

Chikeluo Okeke

General medicine 4 years exp.

Dr Chikeluo Okeke is an internal medicine doctor with extensive international clinical experience. Originally from Nigeria, he has worked across multiple European healthcare systems and currently practises in Sweden. This professional path has given him a strong understanding of different medical approaches and the ability to work effectively with patients from diverse cultural and linguistic backgrounds.

Dr Okeke focuses on general internal medicine and adult primary care, combining clinical accuracy with careful attention to lifestyle, personal context, and everyday health concerns. His consultations are particularly well suited for people who seek medical advice online, live abroad, or need clear guidance without unnecessary complexity.

He provides online consultations covering symptom assessment, prevention, and long-term management of chronic conditions, helping patients understand what is happening and decide on appropriate next steps.

Common reasons for consultation:

  • General internal medicine concerns and initial health assessment.
  • Acute symptoms such as fever, cough, infections, pain, or weakness.
  • Chronic conditions and treatment adjustment.
  • Blood pressure issues, fatigue, metabolic concerns.
  • Preventive consultations and routine check-ups.
  • Interpretation of laboratory results and medical reports.
  • Medical advice for patients receiving care online.

Dr Okeke is known for his clear communication, calm approach, and cultural awareness. He listens carefully, explains medical decisions in a structured way, and supports patients in making informed choices about their health.

Online consultations with Dr Chikeluo Okeke offer reliable internal medicine care without geographic limitations, focused on medical relevance, clarity, and patient comfort.

Get ERBIUM CITRATE (169Er) colloidal CIS BIO INTERNACIONAL 111 MBq/ML INJECTABLE SUSPENSION Prescription Online

1

Fill in a 2-min form

Tell us your symptoms, history, and what medicine you're requesting.

2

Pick a doctor or let us assign

Choose a specialist or we'll match you with the next available doctor.

3

Doctor reviews your case

Usually within 30 minutes. They may ask follow-up questions via chat.

4

Collect from any pharmacy

Electronic prescription sent to your email — valid across Spain.

Frequently Asked Questions

Is a prescription required for ERBIUM CITRATE (169Er) colloidal CIS BIO INTERNACIONAL 111 MBq/ML INJECTABLE SUSPENSION?

ERBIUM CITRATE (169Er) colloidal CIS BIO INTERNACIONAL 111 MBq/ML INJECTABLE SUSPENSION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

What is the active substance in ERBIUM CITRATE (169Er) colloidal CIS BIO INTERNACIONAL 111 MBq/ML INJECTABLE SUSPENSION?

The active ingredient in ERBIUM CITRATE (169Er) colloidal CIS BIO INTERNACIONAL 111 MBq/ML INJECTABLE SUSPENSION is erbium (169Er) citrate colloid. This information helps identify medicines with the same composition but different brand names.

Who manufactures ERBIUM CITRATE (169Er) colloidal CIS BIO INTERNACIONAL 111 MBq/ML INJECTABLE SUSPENSION?

ERBIUM CITRATE (169Er) colloidal CIS BIO INTERNACIONAL 111 MBq/ML INJECTABLE SUSPENSION is manufactured by Cis Bio International. Pharmacy brands and packaging may differ depending on the distributor.

Which doctors can assess the use of ERBIUM CITRATE (169Er) colloidal CIS BIO INTERNACIONAL 111 MBq/ML INJECTABLE SUSPENSION online?

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether ERBIUM CITRATE (169Er) colloidal CIS BIO INTERNACIONAL 111 MBq/ML INJECTABLE SUSPENSION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

How to buy ERBIUM CITRATE (169Er) colloidal CIS BIO INTERNACIONAL 111 MBq/ML INJECTABLE SUSPENSION in Spain?

Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.

You can buy ERBIUM CITRATE (169Er) colloidal CIS BIO INTERNACIONAL 111 MBq/ML INJECTABLE SUSPENSION in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.

To obtain a prescription, you can use Oladoctor:

What are the alternatives to ERBIUM CITRATE (169Er) colloidal CIS BIO INTERNACIONAL 111 MBq/ML INJECTABLE SUSPENSION?

Other medicines with the same active substance (erbium (169Er) citrate colloid) include Rhenium Sulfide (186Re) Colloidal CIS BIO INTERNATIONAL 148-370 MBq/mL Injectable Suspension, Yttrium Citrate (90 Y) Colloidal CIS BIO INTERNATIONAL 37-370 MBq/ml Injectable Suspension, SODIUM IODIDE (I131) CURIUM PHARMA SPAIN 37-7400 MBq CAPSULES. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media